Ganirelix is an injectable gonadotropin-releasing hormone (GnRH) antagonist primarily used in assisted reproductive treatments to prevent premature luteinizing hormone surges. To support the rigorous demands… Read more


























Ganirelix is an injectable gonadotropin-releasing hormone (GnRH) antagonist primarily used in assisted reproductive treatments to prevent premature luteinizing hormone surges. To support the rigorous demands of pharmaceutical quality control, this category provides a comprehensive selection of reference standards, including the active pharmaceutical ingredient, its pharmacopeial and non-pharmacopeial impurities, and stable isotope labelled compounds. These high-quality reference materials are essential for laboratories conducting impurity profiling, method validation, and routine analytical testing. By utilizing these precisely characterized compounds, researchers can ensure the accuracy and reliability of their assays, facilitating consistent monitoring and compliance throughout the drug development and manufacturing lifecycle.